PINEAPPLE EXPRESS CANNABIS Co

PNXP
About the company

Pineapple Express Cannabis Company develops centralized blockchain based Platform as a Service (PaaS) for the cannabis industry. The company is based in Atlanta, Georgia.

Country: United StatesPrice: $0.00Market Cap: $84,273

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

2 / 14

NEUTRAL / FAIL

Median fair value

$0.04

+5614.3% vs price

Models with upside

3 / 17

Positive margin of safety

Strongest signal

PNXP undervalued: all 3 models price fair value above $0.00 (median $0.04)

Key risk

All 12 investors flag PNXP's debt & leverage

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/A+99.0%N/AN/AN/A+96.5%N/A+98.3%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2024 · Balance sheet at 2025-10-31

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-16

Score computed: 2026-11-14

Annual history · FY 2024 · Balance sheet at 2025-10-31 · TTM ended 2025-10-31

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-16

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-16

Score computed: 2026-11-14

Annual history · FY 2024 · TTM ended 2025-10-31 · Balance sheet at 2025-10-31 · Market data at 2026-11-01

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024 · TTM ended 2025-10-31 · Balance sheet at 2025-10-31

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-05-16

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment · Balance sheet at 2025-10-31

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-05-16

Score computed: 2026-11-14

Annual history · FY 2024 · TTM ended 2025-10-31 · Balance sheet at 2025-10-31 · Market data at 2026-11-01

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2025-10-31

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-05-16

Score computed: 2026-11-14

TTM ended 2025-10-31 · Balance sheet at 2025-10-31 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2024

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-05-16

Score computed: 2026-11-14

Annual history · FY 2024 · Balance sheet at 2025-10-31

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Annual history · FY 2024 · TTM ended 2025-10-31 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-12-19

Score computed: 2026-11-14

Where It Passes

  • Valuation models100% pass✓ 3▾

    PNXP undervalued: all 3 models price fair value above $0.00 (median $0.04)

    Dreman fair value$0.07
    ✓Dreman+99.0% margin vs $0.00
    Marks fair value$0.02
    ✓Marks+96.5% margin vs $0.00
    Templeton fair value$0.04
    ✓Templeton+98.3% margin vs $0.00

Where It Falls Short

  • Debt & Leverage0% pass✗ 15▾

    All 12 investors flag PNXP's debt & leverage

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest Coverage
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / EquityN/A (negative equity)
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change
    ✗PiotroskiDecreased YoY
    Current Assets / Current Liabilities0.00
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt LevelsN/A (non-positive equity)
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDA
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)
    ✗AsnessTop 30% of eligible cross-section
  • Valuation0% pass✓ 2✗ 26▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS0.1x
    ✓Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-20.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-20.0%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)
    ✗Dreman< 8x
    Price / Book Value per Share
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value99.1% (IV=$0.07 vs Price=$0.00)
    ✓Marks>= 20% below intrinsic value
    Price / FCF per Share
    ✗Ackman<= 25
    Price vs. Trailing Low140% of trailing low ($0.00)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-774.57%; #6016/6340 (top 94.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization-96.7582; #6384/6449 (top 99.0%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.1919; #3822/5247 (top 72.8%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-68.18%; #5618/6202 (top 90.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✗ 12▾

    All 10 investors flag PNXP's cash flow

    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    FCF Positive and Growing
    ✗LynchPositive and growing
    Operating Cash Flow$-0.0M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROA
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)
    ✗Dreman< 8x
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency1/8 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 4✗ 9▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$0.00 (2017) -> $0.01 (2023)
    ✓DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency0/8 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth21.4%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency1/4 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin -303.0% -> -104.3%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR-17.7%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Efficiency0% pass✗ 11▾

    All 8 investors flag PNXP's efficiency

    Current Ratio0.00
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-25.0%
    ✗Buffett> 10%
    ROIC - WACC-35.0%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.00 -> 0.00
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities0.00
    ✗Dreman> 1.5
    Return on Invested CapitalN/A (non-positive invested capital)
    ✗Munger> 15%
    ROIC (high and growing)FY2022: ROIC=unavailable; FY2023: ROIC=unavailable; FY2024: ROIC=unavailable
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)
    ✗SleepROIC > 12% in a majority of years
  • Verdicts0% pass✗ 14▾

    Split decision: 14 FAIL · 2 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)•GreenblattNot ranked✗PiotroskiFAIL (F-Score 0)✗DremanFAIL (1/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (0/6)✗MarksFAIL (1/5)✗AckmanFAIL (1/9)✗TempletonFAIL (1/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (0/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked)
  • Profitability6% pass✓ 2✗ 33▾

    15 of 16 flag PNXP's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)1/8 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)0/8 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-104.3% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)2.45
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROEN/A (negative equity)
    ✗Lynch> 15%
    EBIT / Enterprise Value-20.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-20.0%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets
    ✗PiotroskiROA > 0
    ROA Change YoY
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROA
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-192.7%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity
    ✗Dreman> 12%
    Margin of Safety
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value99.1% (IV=$0.07 vs Price=$0.00)
    ✓Marks>= 20% below intrinsic value
    Positive Net Income Frequency0/8 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-104.3%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin -303.0% -> -104.3%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-774.57%; #6016/6340 (top 94.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-12.8065; #5713/5884 (top 97.1%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years1/7 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)

Business & financials

Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.

Company Profile

Industry: Business Services
Size: Micro Cap($84,273)
Revenue: $16168.00
Net Income: $-31153.00+47.6% YoY

Financial Snapshot

Operating Margin-104.3%
Return on Equity1498.5%
Debt / Equity--
Current Ratio0.00

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2025-10-31

2024-11-01 – 2025-10-31

Sources · derived quarter values

Derived from cumulative filings: net income, operating income, ebit, pre tax income, operating cash flow.

Q3 FY 2026

2025-08-01 – 2025-10-31

Sources · derived quarter values

Derived from cumulative filings: operating cash flow.

Q2 FY 2026

2025-05-01 – 2025-07-31

Sources · derived quarter values

Derived from cumulative filings: operating cash flow.

Q1 FY 2026

2025-02-01 – 2025-04-30

Sources
FY 2024
Sources
  • 10-K · 2025-05-16
FY 2023
Sources
  • 10-K · 2025-05-16
FY 2022
Sources
  • 10-K · 2023-05-24
FY 2021
Sources
  • 10-K · 2022-04-21
FY 2020
Sources
  • 10-K · 2021-06-08
Market Cap$84.3Kcurrent----------------
Revenue--$0↓100%$0↓100%$0↓100%$16.2K$0↓100%$5.4K↓31%$7.8K↓74%$30.3K
Operating Income-$336.3K↓3636%$110.9K↑8990%-$246.3K↓5839%-$184.6K↓5005%-$16.9K↑72%-$59.5K↓265%-$16.3K↑65%-$46.1K↓336%$19.5K
Net Income-$652.8K↑34%$20.5K↑1739%$16.7K↑288%-$659.3K↓18133%-$31.2K↑48%-$59.5K↓34%-$44.4K↑4%-$46.1K↓136%-$19.5K
EPS (Diluted)----------$0.01$0.00$0.00$0.00
Gross Margin——————100.0%100.0%↑23%81.5%
Operating Margin————-104.3%—-303.0%↑49%-594.6%↓1022%64.5%
ROE8.0%↑100%———1498.5%↑301%373.6%↑4475%8.2%↓90%78.2%↓36%122.6%
Total Debt$3.7M$3.7M$3.7M$3.7M----------
Shareholders' Equity-$8.2M↓28710%-$8.2M↓28710%-$8.2M↓27589%-$8.2M↓32339%-$2.1K↑87%-$15.9K↑97%-$544.4K↓824%-$58.9K↓270%-$15.9K
Current Ratio0.00↓100%0.00↓100%0.00↓100%0.00↓100%0.00↓100%0.000.00↓100%0.07↓47%0.13
Debt / Equity-0.46-0.46-0.46-0.45—————
Operating Cash Flow$905.4K↑3577%$1.8K↑9484%$0$936.9K↑8077%-$45.0K↓150203%$30↑100%-$16.7K↑35%-$25.6K↓1711%-$1.4K
Free Cash Flow------------------

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Business Services

PNXP vs Peers — Financial Grading

Revenue$16168.00Bottom 25%
Net Income$-31153.00Median
ROE1498.5%Top 25%
D/E—
Op. Margin-104.3%Bottom 25%
Curr. Ratio0.00Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
AUTOMATIC DATA PROCESSING INCADP$122.3B$309.93$21.9B$4.4B73.2%0.8224.2%1.054/95/93/70/3F-Score 65/11
ELECTRONIC ARTS INC.EA$52.9B$209.70$7.5B$887.0M13.1%0.2215.4%1.051/94/94/70/3F-Score 66/11
Rubrik, Inc.RBRK$22.6B$109.88$1.3B$348.8M67.1%—-26.2%1.691/90/92/70/3F-Score 62/11
AECOMACM$9.1B$70.50$16.1B$561.8M22.5%1.096.4%1.141/93/93/71/3F-Score 82/11
COMMVAULT SYSTEMS INCCVLT$6.2B$152.07$1.2B$70.7M942.8%—6.3%1.951/92/94/70/3F-Score 66/11
WPP plcWPP$6.0B$27.79$18.2B$289.5M-8.5%1.942.8%0.891/92/91/70/3F-Score 32/11
VARONIS SYSTEMS INCVRNS$5.6B$48.94$623.5M$129.3M-21.6%0.76-23.5%1.971/90/91/70/3F-Score 51/11
ROBERT HALF INC.RHI$4.3B$42.00$5.4B$133.0M10.4%—1.4%1.532/95/91/70/3F-Score 52/11